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Summary
Objective: To determine whether the concentrations of CD44H and v5 and v6 in the synovial fluid are correlated with the presence of
accompanying synovitis in the osteoarthritic joint and with the grade of osteoarthritis.
Design: Using antero-posterior and lateral X-rays of the knee joint and patellar view of 46 patients were graded with the Kellgren & Lawrence
scale. Synovial fluid from these patients with different grades of primary osteoarthritis of the knee joint with and without synovial inflammation
(synovitis) was collected during surgical procedures. A horseradish peroxidase conjugated anti-CD44H-, anti-sCD44v5- or anti-sCD44v6-
antibody was added and labeled with tetramethylbenzidine. The absorbance was measured at wavelengths of 450/620 nm. Regression
analysis was performed and the statistical significance was assessed, using the Student t-test for unequal variance.
Results: CD44H and v5 and v6 were detected in the synovial fluid of all 46 patients. Osteoarthritic patients with synovial inflammation showed
significantly higher levels of CD44H and v6, but not v5, than osteoarthritic patients without synovial inflammation. With progression of
osteoarthritis from Kellgren grade II to III, CD44v5 decreased significantly. All other isoform concentrations remained statistically unchanged.
Conclusions: CD44H and the isoforms v5 and v6 were present in the synovial fluid of osteoarthritic patients. Their concentrations do not
reflect the osteoarthritic stage in the Kellgren grading scale. CD44H and CD44v6, but not CD44v5, are significantly up-regulated in
osteoarthritic synovial inflammation.
Crown Copyright © 2003 Published by Elsevier Ltd on behalf of OsteoArthritis Research Society International. All rights reserved.
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Introduction
CD44 is a transmembrane glycoprotein with the ability to
bind extracellular human cartilage matrix components like
fibronectin, collagen types I and IV and hyaluronan. It was
identified as the principal cell-surface receptor for hyaluro-
nan and as the extracellular matrix receptor type III1–5.
CD44 was first described by Dalchau et al.6 and its expres-
sion was identified in chondrocytes of normal and osteoar-
thritic cartilage7 as well as in the synovial tissue8 of
osteoarthritic patients. However, the survival of measur-
able amounts of CD44 in the human synovial fluid of
osteoarthritic patients was not reported.
CD44 occurs in a standard isoform (CD44H) and in
several isoforms9 as alternatively spliced variant exon-
encoded gene products8. Its isoform diversity is determined
by variable exon usage, glycosaminoglycan substitution,
and cell type-specific N- and O-linked glycosylation10. The
standard isoform CD44H is expressed most broadly1,3,10. It
has a molecular mass of 90 kDa and lacks the variable
exons 6–15. The alternatively spliced isoforms are CD44
variants 1–10 (CD44v1–v10). They contain the variable
exons 6–15 and molecular mass ranges to more than
250 kDa for isoforms containing all of the variant exon
products and high molecular weight glycosaminoglycans
(v10).
The physiological functions of CD44H and its isoforms
are complex and not completely understood although
a number of different functions have been described. The
isoforms of CD44 are linked to a high rate of cell divi-
sion11,12. CD44v5 is involved in gastric cancer13,14 and in
the settlement of melanoma cells in lymph node tissue15. In
a rat colon carcinoma model, CD44v6 is correlated with
tumorigenicity16. Another function of CD44v6 (and v9) is
the involvement in the in vivo differentiation of monocytes
to tissue macrophages in inflammatory sites17,18. The
standard form of CD44 is implicated in cell–cell adhesion
and cell attachment to the extracellular matrix4, cell migra-
tion19, tissue remodeling20, lymphocyte activation21,
re-circulation and homing20. Additionally, CD44 mediates
the release of interleukin1- (IL1-) and tumor necrosis
factor (TNF-)22.
In human cartilage the turnover of hyaluronan23 is
mediated in part by CD44. Hyaluronan is maintained at
high concentrations within the cartilage matrix, creating the
osmotic swelling forces that are needed for compression
resistance. The role of CD44 as a mediator of the turnover
of hyaluronan is thought to be a key feature for cartilage
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matrix function and maintenance. The expression of CD44
was shown in chondrocytes of normal and osteoarthritic
(OA) tissue7. Surprisingly, the absence of the isoforms
CD44v8, v9 and v10 was shown in the same cartilage
samples7. In non-degenerative articular cartilage the CD44
expression shows a distinct zonal variation, which is lost
with osteoarthritic changes24. Furthermore, the inhibition of
CD44 expression in cartilage, by anti-sense oligonucleo-
tides, causes a near-total loss of proteoglycan-rich matrix25
and therefore leads to a change in the biomechanical
properties of articular cartilage. However, in synovial tissue
of osteoarthritic patients the isoforms v6–v7, v5–v9 and
v2–v10 were identified8. It is our hypothesis that CD44H
and several isoforms are probably secreted into the
synovial fluid from both synovial tissue and articular carti-
lage and may act on both synovial tissue and articular
cartilage, thus leading to synovial inflammation in osteo-
arthritis and adding to the progression of osteoarthritis in
cartilage.
The purpose of this study is to identify CD44H and the
isoforms v5 and v6 in the synovial fluid of the osteoarthritic
human knee joint. It is known that CD44H and the isoforms
CD44v5 and CD44v6 are present in the synovial tissue8 but
secretion into the synovial fluid and survival of these
isoforms are not analyzed. Furthermore, this study
assessed if the concentrations of CD44H and the isoforms
CD44v5 and CD44v6 in the synovial fluid are correlated
with the presence of accompanying synovitis in the osteo-
arthritic joint and with the grade of osteoarthritis.
Materials and methods
Antero-posterior and lateral X-rays of the knee joint and
patellar view of 46 patients were taken one day before
surgery and collection of synovial fluid specimen. The
Kellgren & Lawrence osteoarthritis grading scale26 was
used (Table I gives the Kellgren & Lawrence grading
system). All X-rays were graded by a single orthopedic
surgeon to whom the patient history was unknown. The
osteoarthritis grading and the total n for each category are
given in Table II. Synovial inflammation was diagnosed
during surgery by gross evaluation of the synovial mem-
brane and the procedure was performed blinded to any
biochemical results. Synovial specimens were collected
intraoperatively and later analyzed histologically by clinical
routine criteria (Table II gives the number of patients with
synovitis). Patients with Kellgren & Lawrence grades II–IV
underwent total knee joint replacement and patients with
Kellgren & Lawrence grade 0 suffered from joint pain and
underwent arthroscopy. No Kellgren & Lawrence grade I
patients are included in the present study.
BIOCHEMICAL AND STATISTICAL METHODS
Synovial fluid from 46 patients, 18 males and 28 females,
average age 59.5 years (SD, 12.8; range, 25–80 years),
and with different grades of primary osteoarthritis of the
knee joint with and without synovial inflammation (synovi-
tis) was collected during surgical procedures. In order to
remove synovial hyaluronan to prevent non-specific bind-
ing in the ELISA analyses, hyaluronidase at a final concen-
tration of 1 µg/ml (synovial fluid) was added within one hour
after collection and incubated for 30 min at room tempera-
ture. After centrifugation (1000×g for 5 min), the super-
natant was collected and stored at −70°C until assayed. No
cell counts were performed prior to storage. ELISA-Kits for
soluble CD44H, soluble CD44v5 and soluble CD44v6 were
purchased from Bender MedSystems, Wien, Austria. After
thawing, the samples for CD44H ELISA were diluted to
1:60. CD44v5 samples were diluted to 1:10 and CD44v6
samples were diluted to 1:3. All standards and synovial fluid
samples were analyzed in duplicate, following the manu-
facturer’s protocol. The ELISA-Kits included a horseradish
peroxidase (HRP) conjugated primary monoclonal anti-
body, anti-CD44H-, anti-sCD44v5- or anti-sCD44v6-
antibody and were based on a chromogenic reaction with
the substrate tetramethylbenzidine. The absorbance of
each sample and standard was measured in duplicate by a
spectrophotometric plate reader (Microplate Reader) at
dual wavelengths of 450/620 nm. The duplicate absorb-
ance values for the standards and all samples were aver-
aged. The average zero standard absorbance value was
subtracted from each averaged standard and sample
value. The mean absorbance values (O.D.) for each of the
standards vs the concentration of each standard were
plotted and regression analysis was performed. All sample
concentrations were calculated by interpolation from
the standard curve and multiplication by the dilution factor.
Regression analysis with Microsoft Excel® was performed
to evaluate the standard curve. This program was also
used to calculate the concentrations of CD44 isoforms and
for descriptive data analysis. For evaluation of statistical
significance the separate-variance t-test was performed.
CONTROLS
As positive control, commercially available standard
solutions containing known concentrations of CD44H,
sCD44v5 and sCD44v6 (Bender MedSystems, Wien,
Austria) were used. The wash buffer served as negative
control.
ELISA SPECIFICATIONS
According to the manufacturer, the sensitivity of the
CD44 ELISA is 0.023 ng/ml. The intra-assay coefficient of
variation is 4.8%, the inter-assay coefficient of variation is
4.1%. Cross-reactivity with TNF-, TNF-, TNF-R, IFN-a2c,
IL-8 annexin, SECAM-1, SL-selectin, sICAM-1 and HER-2
is excluded. According to the manufacturer, the sensitivity
Table I
Kellgren & Lawrence grading system
Grade Joint features
0 No features
I Minute osteophyte, doubtful significance
II Definite osteophyte, unimpaired joint space
III Moderate diminution of joint space
IV Joint space greatly impaired, sclerosis of subchondral
bone
Table II
Osteoarthritis grading of 46 patients
Kellgren Number of
patients
Percentage Patients with
synovitis
0 2 4.4 1
I 0 0 0
II 3 6.5 2
III 8 17.4 3
IV 33 71.7 4
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for human CD44v5 is 0.22 ng/ml, the intra-assay coefficient
of variation is 3.6% and the inter-assay coefficient of
variation is 5.8%. Cross-reactivity with several structurally
related and non-related polypeptides, including CD44
polypeptides that lack the protein sequence encoded by
exon 5, is excluded. According to the manufacturer, the
sensitivity for human CD44v6 is 0.09 ng/ml, the intra-
assay coefficient of variation is 3.0% and the inter-assay
coefficient of variation is 4.2%. Cross-reactivity with CD44
polypeptides that lack the protein sequence encoded by
exon 6 is excluded.
Results
Soluble CD44H and the soluble isoforms v5 and v6 were
detectable in the synovial fluid of all 46 patients examined
(Fig. 1) with the standard isoform CD44H showing the
highest synovial concentrations. In the synovial fluid of
osteoarthritic patients with accompanying synovial inflam-
mation the concentrations of all the CD44 isoforms were
higher than in the synovial fluid of osteoarthritic patients
without synovial inflammation. However, there was a sig-
nificant difference between osteoarthritic patients with and
without accompanying synovial inflammation in the syn-
ovial concentrations of CD44H (P0.0004) and CD44v6
(P0.0134) but not CD44v5 (P0.1501).
There were no significant differences between the osteo-
arthritis Kellgren grades II, III and IV in the concentrations
of the standard isoform CD44H (Fig. 2) but there was a
tendency towards a decrease in concentration of CD44H
with increasing Kellgren grade (P for CD44H Kellgren II vs
III=0.126, P for CD44H Kellgren II vs IV=0.231, P for
CD44H Kellgren III vs IV=0.455). The synovial concen-
trations of the isoform CD44v5 showed a significant differ-
ence between the osteoarthritis Kellgren grades II and III
(P0.039) but not between the remaining Kellgren grades
(Fig. 3). Additionally, there was no significant difference
between non-osteoarthritic patients and osteoarthritic
patients. Similar to CD44v5, the synovial concentrations of
CD44v6 showed no significant differences in any Kellgren
grade or between non-osteoarthritic and osteoarthritic
patients (Fig. 4). However, the synovial concentrations of
all isoforms examined showed an increasing tendency with
the onset of osteoarthritis from Kellgren grade 0 to II and a
decreasing tendency with increasing Kellgren grade. These
changes in the synovial concentrations were not significant
except for CD44v5 in Kellgren grade II vs III.
Discussion
In summary, osteoarthritic patients with accompanying
synovial inflammation showed significantly higher synovial




+¡6\Q +6\Q 9¡6\Q 96\Q 9¡6\Q 96\Q
&'

LV
RI
RU
P
V
XJ
P
O
Fig. 1. Concentration of CD44 isoforms (µg/ml) in all osteoarthritic patients with and without synovial inflammation (synovitis)±SD. H øSyn,
CD44H without synovitis; H Syn, CD44H with synovitis; v5 øSyn, CD44v5 without synovitis; v5 Syn, CD44v5 with synovitis.
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Fig. 2. Concentration of CD44H (µg/ml)±SD in the osteoarthritis grading scale of Kellgren grades II, III, IV.
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levels of CD44H and the isoform v6 than osteoarthritic
patients without accompanying synovial inflammation.
Synovial concentrations of CD44v5 in osteoarthritic
patients were not significantly elevated with accompanying
synovial inflammation. Clinically, synovial inflammation
often accompanies osteoarthritis. According to Johnson
et al.27, the degree of synovial inflammation is related to the
level of CD44 present in the synovial tissue.
Hale et al.8 identified the CD44 isoforms v6–v7, v5–v9
and v2–v10 in the synovial tissue of osteoarthritic patients.
Our results suggest that CD44H and CD44v6 and not
CD44v5 have been synthesized and secreted and do
survive in the synovial fluid of osteoarthritic patients. The
elevated CD44v6 levels in synovitis may be related to the
fact that v6 is involved in the activation of immune cells28,
while the thickening of the synovial membrane in osteo-
arthritic synovitis may be explained by the involvement of
CD44 isoforms in an accelerated rate of cell division.
Additionally, the release of the inflammatory cytokines IL-1
and TNF is CD44 mediated and may be responsible for
the synovial inflammation in degenerative osteoarthritis. In
a clinical situation, primary osteoarthritis and acute synovial
inflammation of the human knee joint often lead to acceler-
ated joint destruction and a thickened synovial membrane,
which has to be excised during arthroplasty to avoid
continuing episodes of non-bacterial inflammation and
knee pain. After arthroplasty, painful episodes of unknown
origin are probably caused by a non-infectious chronic
synovitis or by a septic or aseptic loosening of the implant.
The analysis of CD44H and CD44v6 concentrations in
the synovial fluid may help to distinguish between these
diagnoses.
Osteoarthritis is, after onset, slowly progressive29, and
the catabolic effect on articular cartilage loss over time is
clinically and radiologically represented in the grade of
osteoarthritis. Nevertheless, the Kellgren grading system
addresses only the radiological dimensions of osteo-
arthritis. Even Kellgren grade II is characterized by yet
unimpaired joint space, but with the appearance of definite
osteophytes as expression of additional bone modeling.
The progression of osteoarthritis from Kellgren grade II to
grade III includes a moderate diminution of the joint space,
which is a radiological measurement of loss of articular
cartilage. With the progression of osteoarthritis to this stage
the synovial concentration of CD44v5 decreased signifi-
cantly but all other isoform concentrations remained stat-
istically unaffected. Cartilage metabolism and especially
the ratio of cartilage collagens and proteoglycans may
already be altered in the early stages of osteoarthritis,
while radiological features are still not apparent. For these
reasons the Kellgren grading system may not be suitable to
correlate radiological features of osteoarthritis with carti-
lage metabolism or with synovial concentrations of CD44
isoforms. Indeed, the synovial concentrations of CD44H
and the isoforms v5 and v6 did not significantly reflect a
certain degenerative stage of osteoarthritis in the Kellgren
grading scale. The decrease in synovial concentrations
with increasing Kellgren grades may account for a CD44
response to a positive feedback in a sense of ongoing or
satisfactory repair. In later osteoarthritis the decrease in
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Fig. 3. Concentration of CD44v5 (µg/ml)±SD in the osteoarthritis grading scale of Kellgren grades II, III, IV.
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Fig. 4. Concentration of CD44v6 (µg/ml)±SD in the osteoarthritis grading scale of Kellgren grades II, III, IV.
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synovial concentrations may be due to a ‘burnt out’ control
mechanism and a consecutive downregulation of the repair
attempt. Interestingly, the later stages of osteoarthritis
demonstrated CD44v5 and v6 concentrations, which were
below the physiological level in non-osteoarthritic patients.
These findings support the concept of a possible ‘burnt out
syndrome’ of CD44v5 and v6 in later osteoarthritis: altered
synovial fluid levels of CD44H and v5 and v6 may fail to
support the maintenance of the cartilage matrix and its
load-bearing function and lead to progression of osteo-
arthritis. On the other hand, the expression of CD44 iso-
forms may be regulated at a posttranscriptional level and
the isoforms CD44v5 and v6 may be expressed only for a
brief period of time. Amounts, which are representative for
a certain stage of osteoarthritis, may only be detectable in
the synovial fluid during these brief periods of time. Future
messenger RNA studies of cartilage and synovial tissue
with regard to different osteoarthritis grades are needed to
address this problem.
In conclusion, CD44H and the isoforms v5 and v6 were
detected in the synovial fluid of all patients examined but
their synovial concentrations were not significantly elevated
with advancing stages of osteoarthritis in the Kellgren
grading scale. Of all CD44 isoforms analyzed CD44H
showed the highest synovial concentrations. CD44H and
CD44v6 but not CD44v5 concentrations were significantly
higher in osteoarthritic patients, who had accompanying
synovial inflammation than in osteoarthritic patients without
synovial inflammation. This might be explained by the fact
that there were fewer high grade Kellgren samples with
inflammation than lower grade samples. With the progres-
sion of osteoarthritis from Kellgren grade II to grade III the
synovial concentration of CD44v5 decreased significantly.
All other isoform concentrations remained statistically
unchanged.
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